From Distrust to Confidence: Can Science and Health Care Gain What’s Missing?

Since the COVID-19 pandemic shook the globe four years ago, headlines and public conversations have focused on the public’s trust—and the lack of it—in science and medicine.
But trust, mistrust, and distrust—we’ll get to the meaning behind those terms—have been changing shape in the U.S. for decades. Surveys show declines in trust in health care, especially among populations that historically have been harmed by medical research and scientific abuses whose legacies persist today.
As a licensed clinical psychologist, behavioral scientist, and health disparities researcher, I have witnessed these effects up close on a professional level:
A middle-aged Black American patient with late-stage head and neck cancer, whom I treated for anxiety and depression some years ago, delayed seeking medical care because of prior negative experiences with doctors (such as perceived disrespect and the hesitation of clinicians to touch him during physical exams); a preference for natural remedies (such as herbs and vitamins); costly medical bills; and a history of repeated clinic visits for other symptoms with no diagnoses but multiple prescriptions. By the time he sought help, the lump on his neck had grown to the size of a large apple, and the cancer had spread to other organs.
Still another example was a woman who is a member of my own family. A mother of six, she had such negative experiences in medical settings over the years and during previous pregnancies—feeling ignored and minimized, not given pain medication when needed, and discriminated against because of her race by White doctors—that she skipped all prenatal care and went to the ER only when she went into labor with her last three children, requesting cesarean sections based on her past deliveries.
And I’ve been affected by these concerns on a personal level through my own experiences in medical settings, and simply by the fact that I’m a Black American woman in a field that has historically marginalized people like me. I was moved to partner with a community advisory board I worked with on research called the Forward Movement Project, which asked patients and residents from medically underserved populations to weigh in on health care concerns. The findings from this study and other research and surveys make clear that today many Americans deliberately avoid seeking out health care or participating in medical research until they have no other choice, reflecting personal and community experiences with these institutions that have led to widespread and deeply rooted medical distrust.
Trust, mistrust, and distrust: defining the terms
The psychological concepts of trust, mistrust, and distrust are interconnected, yet distinct and nuanced.
Trust refers to a belief in the reliability or ability of an individual or institution. In health care and science, it’s essential for cooperation and compliance with health interventions, treatment plans, and science-based clinical guidelines as well as clinical trial participation. Studies show that patients who trust their clinicians are more likely to follow medical advice, seek help when needed, and maintain ongoing care.
Mistrust involves a vague unease or a gut feeling of skepticism, often based on past experiences, but has not yet become full-stop rejection. The sources of the doubt may not always be clear. In health care, mistrust may lead to hesitating to accept information, expressing concern about the motives for a treatment plan, or seeking second opinions specifically for validation. The scientific literature often refers to mistrust for science and medicine especially among racial and/or minority populations, but distrust is the more accurate term.
Distrust is more severe than mistrust, and reflects a firm belief that doctors, scientists, and/or health care institutions are untrustworthy, often rooted in personal or community experiences of harm or betrayal. It can result in underutilization of health care services, belief in conspiracy theories, or outright rejection of medical advice.
And, unfortunately, history is replete with cases that fuel distrust for many people.
Historical sources of medical distrust
The U.S. Public Health Service Untreated Syphilis Study at Tuskegee is one of the most infamous examples of institutional betrayal, fueling deep distrust in science and health care, particularly among Black Americans.
From 1932 to 1972, Black men with syphilis were misled into believing they were receiving free health care but were deliberately left untreated, even after penicillin was found to be a cure. This unethical study symbolizes racial exploitation in medicine. Although its ongoing impact on distrust is debated, Tuskegee has left a legacy of institutional distrust for many Black Americans.
And there are other egregious examples of human exploitation and intentional harm in science and health care that targeted specific communities.
The eugenics movement in the early 20th century in the U.S. aimed to eliminate what its proponents considered “undesirable” traits within the population. This movement sought to “improve” the human gene pool by promoting traits associated with White individuals and those without visible disabilities who were considered the most “fit.” Consequently, Black women and Latinas, including many Puerto Rican women, endured decades of coerced sterilization that persisted into the 1970s. 
Even more recently, in 1989, members of the Havasupai Tribe, a small, economically disadvantaged Tribe of 650 people, asked an Arizona State University professor for help in understanding and addressing the increase in diabetes in their community. They supplied genetic samples, only to later learn that those samples were also used for purposes they had not consented to—including research on inbreeding and alcoholism. They brought a lawsuit against the university that was settled in 2010 with the samples returned, a monetary settlement, and help obtaining funding for a health clinic.
Recent sources of distrust: COVID-19 and beyond
The COVID-19 pandemic brought distrust in science and health care to the forefront, particularly among Black or African American, Latino or Hispanic, American Indian or Alaska Native, and Native Hawaiian or Pacific Islander populations, who experienced disproportionately high rates of infection, hospitalization, and death—especially in 2020, 2021, and 2022.
Despite the rapid development of COVID-19 vaccines thanks to years of mRNA research, vaccine hesitancy and low uptake were widespread.
Although political discourse, misinformation, and disinformation played roles, vaccine hesitancy among populations experiencing health disparities stemmed from historical roots as well as ongoing experiences of discrimination and neglect within the health care system.
The hesitancy, particularly in communities hardest hit by COVID-19, didn’t surprise me. Many patients I encountered expressed concerns like, “We don’t want the vaccines at all” or “We don’t want the vaccines first.” People feared they would receive a “bad batch,” questioning why underserved communities were suddenly prioritized for the first time in modern U.S. history.
Ironically, the prioritization was due to public health leaders’ aim to promote racial and ethnic equity in vaccine access. But the long-standing and justified distrust left many skeptical—showing just how challenging building trust in many communities will be. This distrust extends beyond vaccines, affecting areas such as cancer treatment, maternal health, and mental health services, where access and outcome disparities persist.
The conversation around distrust in science and medicine tends to focus on racial and ethnic minority populations, though a Gallup Poll indicated that only 36% of U.S. adults overall say they have a great deal of confidence in the medical system, compared with 80% in 1975.
Moreover, other populations experiencing health disparities—including sexual and gender minority groups, people with low socioeconomic status, people living in underserved rural areas, and people with disabilities—also report trust-related concerns for clinicians or the health care system because of the way they are treated.
These concerns are ripe for repair. But building trust will require hard work and showing trustworthiness and genuine engagement with the people who have the least confidence.
The Forward Movement Project
My own research on distrust in science and health care, the Forward Movement Project, offered an approach for examining these significant issues. We created a community-academic partnership to understand some aspects of the multilayered factors related to trust or distrust. Our community advisory board members were involved in every step of the research process—from identifying priorities to developing an intervention—giving them a sense of ownership and agency that are critical to rebuilding trust. We first went on a “listening tour,” hosting town hall-style meetings with members of underserved communities.
The research participants spoke candidly about their personal experiences, as well as those of their family and friends, within medical settings, and many were related to their current medical distrust. “We don’t trust the system, because it can’t be trusted. Health care should come first, but it’s become a business,” one person told us. Another said, “Trust was broken long ago in the African American community when it comes to medical research. People should be informed before they agree to participate, but the health care system hasn’t done enough to ease our concerns.” We shared the findings with hospital leadership, clinicians, other researchers, and the very people we listened to.
Based on comments like these, the challenges for repairing confidence in the medical system loomed large. A key finding from the Forward Movement Project was the importance of reciprocal trust-building between communities and institutions. Participants stressed that trust must be earned through transparency, accountability, and collaboration, with institutions showing a willingness to listen, learn, and adapt their practices based on community input.
So, about a year later, we returned to the same neighborhoods for the second phase of the research, bringing clinicians with us so that they could talk directly with community members and answer questions raised about the health care system. This was what we called a “user-generated” intervention, which consisted of participant-driven dialogues with oncology clinicians and support professionals. This was a rare opportunity for conversations between community members and health care professionals and researchers, allowing participants to discuss their questions about care, and to initiate important discussions. Findings from this second phase of the project were positive and indicated that this activity helped people learn new things about science and medicine and would help them during future medical encounters, and over half reported more willingness to join a clinical trial than before the intervention. This kind of open communication is a crucial first step toward building trust.
The Forward Movement Project also highlighted the importance of representation in reducing distrust. Community participants noted that racial or ethnic matching with clinicians improves culturally competent communication and empathetic care. Other research supports increasing the number of scientists and health care professionals from underrepresented backgrounds to create a workforce that better reflects the communities it serves.
The road toward trust
Trust is a fragile, underappreciated psychological construct that must be earned and is difficult to repair once broken. In that way, institutional distrust is not unlike repeated betrayals in personal relationships, but on a much larger and intergenerational scale.
It’s up to those with power and authority to take concrete actions for improvement so biomedical institutions and health care systems hold the primary responsibility for addressing distrust. Here are some ways they could start:
Publicly acknowledge the historical wrongdoings that have contributed to distrust, such as the Tuskegee syphilis study and forced sterilizations. This includes issuing apologies, acknowledging ongoing harm, and outlining the tangible steps to ensure that these violations never happen again.
Recruit and retain well-qualified individuals from underrepresented backgrounds at all levels—from students to leadership positions. Reflecting the diversity of the populations served is important, as is ensuring that these persons are committed to the intentional and long-term efforts needed to make progress on building trust.
Implement continual and comprehensive training on factors known to influence trust and distrust, such as cultural competency, bias, and practices and policies that foster and maintain inequities.
Invest in long-term partnerships with communities, not just when there is a need for research participants or representatives to serve on patient advocacy boards without decision-making authority. The exchange of knowledge is critical, and community members can offer informed views on health care policy, research agendas, and institutional priorities.
Move beyond traditional metrics of success such as patient satisfaction surveys, and instead work with communities to define what successful relationships and outcomes look like, which might include measures of trust, community empowerment, and perceived respect. This also involves engaging in health education, supporting local health initiatives, and contributing to overall community well-being.
Demonstrate a genuine desire to build and maintain trusting relationships. This will require efforts to strengthen oversight and accountability, such as independent panels consisting of scientists, clinicians, and community voices; community-identified and well-resourced public health initiatives; regular equity-focused audits of policies, treatment, and health outcomes, research enrollment and patient demographics; and corrective actions when disparities are identified.
Reducing distrust that has built up over a long time is far from simple. However, science and health care institutions can choose to take proactive, transparent, and sustained steps toward rebuilding trust. Equally important, they should raise awareness at local, state, and national levels about their efforts to prioritize the best interests of all communities for a more equitable future.
Monica Webb Hooper is a clinical psychologist and deputy director of the National Institute on Minority Health and Health Disparities at the National Institutes of Health.

How scientists are using £1m to develop climate resilient raspberries at Scottish research centre

A changing climate, rising production and labour costs, and the reduction of available pest and disease control measures pose severe risks to the raspberry industryA project researching climate change-resilient raspberries has been awarded £1m in funding. The Raspberry Economics in Production project, led by the James Hutton Institute, was given the substantial cash injection from UK Research and Innovation’s (UKRI) Innovate UK as part of a programme to focus on improving the sustainability of raspberry production in the UK.JHI, which has centres in Dundee and Aberdeen, said the project will focus on developing raspberry varieties that require less water, fertiliser and labour to grow.The overwhelming majority of raspberries sold in the UK are grown in Scotland where the long summer days help produce the most delicious berries.Scotland is renowned for its raspberry production and is known for producing some of the best raspberries in the world.

Bradbury Science Museum Director Linda Deck Honored At Special Retirement Open House

Linda Deck, center, and LANL Division Leader Community Partnerships Division Kathy Keith, center left, at the retirement open house held Wednesday, Oct. 2 where colleagues and friends gathered to honor Deck in her retirement after serving 17 years as director of the Bradbury Science Museum. Photo by Carol A. Clark/ladailypost.com
Bradbury Educator Chelsea Redman and Exhibit Designer and Manager Omar Juveland on behalf of the staff, present Linda Deck with a special wall hanging covered with memories of projects they worked on together during Deck’s 17 years as Bradbury director. Photo by Carol A. Clark/ladailypost.com
By CAROL A. CLARKLos Alamos Daily [email protected]
Scientist and former staff of the Smithsonian Linda Deck was deemed a perfect fit at her interview 17 years ago to lead the Bradbury Science Museum.
She had been working as director of the Idaho National History Museum for about five years, and being open to challenges outside of paleontology spotted the announcement seeking a director for the Bradbury Science Museum.
“I thought it looked interesting … it’s almost like the Smithsonian because there are so many great researchers with so many great stories to tell,” Deck said. ”I heard back rather quickly. They liked my good museum background but also someone who knew how to engage in the community and main street. They offered me the job and I took it without knowing much about it so I had a huge learning curve. When I read Bradbury in the ad, I thought, ‘Ray Bradbury’ like so many do.”
Her first day on the job was Aug. 27, 2007 and by all accounts from the crowd of colleagues, community leaders and friends who filled an open house event to honor her 17 years later on Oct. 2, she really was a perfect fit.
“When I first began working here the thing that surprised me the most … I was amazed at how broad the laboratory was and how hard it was to find information,” Deck said. “It’s almost gone 180 degrees from then to now with a coordinated effort by the Lab to communicate the good works of the laboratory including the Bradbury.”
She describes the highlight of her career at the Bradbury as the recent completion of the Nuclear Weapons Exhibit.
“This project has been the most rewarding. There would be no exhibit for me that could ever top this one,” Deck said. “I had wonderful support from 150 people across the Lab who worked together on this exhibit and it was a joy every day to interact with them.”
She commended everyone she has worked with at the Lab and their dedication.
“My Heart is full. It has been my privilege to have been the director of the museum,” Deck said.
People have asked her if she will move away.
“I wasn’t born in New Mexico but I got here as soon as I could … I’m not leaving.”
Deck is honored and thanked for her leadership and dedication:
LANL Director Thom Mason: “For 17 years, Linda Deck has been sharing the Laboratory’s history and legacy with educators, students, science enthusiasts in the Northern New Mexico community as well as visitors worldwide. Thanks to her stewardship of the Bradbury Science Museum, the world has a deeper understanding of our mission.”
John Hopkins, LANL retired senior scientist: “I want to congratulate Linda Deck for her superb accomplishments as the Bradbury Science Museum director over her seventeen years. She has been innovative, skillful, and most of all a great and most loved leader. She knows the role of a museum. It has been developed to explain in contemporary terms the role and contributions of the Los Alamos National Laboratory from the Manhattan days of World War Two up through the present and into the future. She will be a challenging act to follow, but the new director has the drive, experience and knowledge to fill the bill. We wish him well.”
LANL Division Leader, Community Partnerships Division Kathy Keith: “As the longest serving Director of the Bradbury Science Museum, Linda has left a legacy of exhibits that communicate the important technical work done at Los Alamos National Laboratory. We are thankful for the energy and expertise she brought to the Bradbury.”
Johnnie Martinez, retired community relationships manager: “Thank you, Linda, for your 17 years of leadership at the Bradbury Science Museum, and congratulations on your retirement! As I look back on those years, I’m proud to declare we made the right decision when we asked you to join our management team. Your energy, enthusiasm, and experience made a huge and lasting impact on the Museum, the Laboratory, and community it serves!”
Los Alamos County Manager Anne Laurent: “I would like to thank Linda for all her contributions toward our community’s history telling, tourism, and supporting the creation of the Manhattan Project National Historic Park. We are forever grateful and appreciative of her talent and partnership. Congratulations Linda!.”
Bradbury Exhibit Designer and Manager Omar Juveland: “Linda Deck came to the Bradbury as a scientist and former museum director from Idaho with a strong background and passion for exhibit development from her years at the Smithsonian National Museum of Natural History. If you look back at the Bradbury Science Museum galleries in 2007 when Linda started and compared them to today, you will see a completely different museum—every gallery and exhibit here, with a few exceptions, has been changed or updated. Each exhibit project takes about a year to develop, write, design, produce, and install. Linda has been a part of every exhibit project and not only with exhibit development—but also with finding the people, organizations, and funding to get these all produced. Exhibits may make a museum, but being the director of the Bradbury also required managing education and outreach programs including years of LANL New Hire presentations, monthly Periodic Table science chat events, and producing the Lab’s Challenge Tomorrow trailers. She also started the museum’s nonprofit, The Bradbury Science Museum Association, as a means to fund educational outreach and bring northern New Mexico schools to the Bradbury.”
Johnnie Martinez, retirned LANL community relationships manager honors Linda Deck on her retirement during the open house Oct. 2 at the Bradbury Science Museum. Photo by Carol A. Clark/ladailypost.com
LANL Division Leader, Community Partnerships Division Kathy Keith honors Bradbury Science Museum Director Linda Deck on her retirement during the open house Oct. 2. Photo by Carol A. Clark/ladailypost.com
Scene from the Retirement Open House held Oct. 2 to honor Bradbury Science Museum Director Linda Deck. Photo by Carol A. Clark/ladailypost.com
Scene from the Retirement Open House held Oct. 2 to honor Bradbury Science Museum Director Linda Deck. Photo by Carol A. Clark/ladailypost.com
Bradbury Science Museum Director Linda Deck, left, receives a bouquet of dahlia flowers from Liddie Martinez in honor of her retirement. Photo by Carol A. Clark/ladailypost.com
Scene from the Retirement Open House held Oct. 2 to honor Bradbury Science Museum Director Linda Deck. Photo by Carol A. Clark/ladailypost.com
Bradbury Science Museum Director Linda Deck in her office Oct. 2. Photo by Carol A. Clark/ladailypost.com

Scientists Uncover Genes Unique to Humans That May Trigger Autism

Researchers discovered two human-specific genes that affect synapse development and may help explain neurodevelopmental disorders like autism, providing new avenues for treatment. Credit: SciTechDaily.com
Human-specific genes control a crucial gene associated with autism spectrum disorders.
The human brain’s unusually extended development, which sets it apart from other mammals, is believed to play a key role in our advanced learning abilities. Interruptions in this process could help explain some neurodevelopmental disorders.
Now, a team of researchers led by Prof. Pierre Vanderhaeghen (VIB-KU Leuven), together with scientists of Columbia University and Ecole Normale Supérieure has discovered a link between two genes, present only in human DNA, and a key gene called SYNGAP1, which is mutated in intellectual disability and autism spectrum disorders. Their study, published in Neuron, provides a surprisingly direct link between human brain evolution and neurodevelopmental disorders.
The human brain stands out among mammals for its remarkably prolonged development. Synapses – critical connections between neurons of the cerebral cortex, the brain’s main hub for cognition – take years to mature in humans, compared to just months in species like macaques or mice. This extended development, also known as neoteny, is thought to be central to humans’ advanced cognitive and learning abilities. On the other hand, it has been hypothesized that disruptions of brain neoteny could be linked to neurodevelopmental disorders such as intellectual disability and autism spectrum disorder.
A dendrite – an extension of a neuron – from a 12-month-old human cerebral cortex neuron, grown from human stem cells and transplanted into a mouse cerebral cortex. Two human-specific genes, SRGAP2B and SRGAP2C, were turned off, causing the neuron’s synapses to mature faster. The number of small protrusions on the dendrite, called dendritic spines, resembles what is typically seen in a five to ten-year-old child. Credit: Baptiste Libé-Philippot, 2024
The lab of Pierre Vanderhaeghen at the VIB-KU Leuven Center for Brain & Disease Research previously discovered that the prolonged development of the human cerebral cortex is mainly due to human-specific molecular mechanisms in neurons. Now, they are investigating these molecular timers in human neurons.
Unlocking the secrets to slow synapse development
In their latest study, the team tested the involvement of two genes, SRGAP2B and SRGAP2C, which are unique to humans. First identified by Cécile Charrier in the laboratory of Prof. Franck Polleux (Columbia University, USA), these genes have been found to slow down synapse development when artificially introduced into mouse neurons of the cerebral cortex. The question if these genes function the same way in human neurons has remained unanswered.
To address this, Dr. Baptiste Libé-Philippot, a Postdoctoral Fellow in the Vanderhaeghen lab, switched off SRGA2B and SRGAP2C in human neurons, transplanted them into mouse brains, and carefully monitored synapse development over an 18-month period.
“We discovered that when you turn off these genes in human neurons, synaptic development speeds up at remarkable levels,” says Dr. Libé-Philippot. “By 18 months, the synapses are comparable to what we would expect to see in children between five and ten years old! This mirrors the accelerated synapse development observed in certain forms of autism spectrum disorder.”
Clues to human-specific brain disorder susceptibility
The team then investigated the underlying genetic mechanisms behind the pronounced effects of SRGAP2B and SRGAP2C on human neuron neoteny. They focused on the SYNGAP1 gene, an important disease gene known to be involved in intellectual disability and autism spectrum disorder.
Remarkably, they discovered that the SRGAP2 and SYNGAP1 genes act together to control the speed of human synapse development. Most strikingly, they found that SRGAP2B and SRGAP2C increase the levels of the SYNGAP1 gene and can even reverse some defects in neurons lacking SYNGAP1. This finding increases our understanding of how human-specific molecules influence neurodevelopmental disease pathways, shedding light on why such disorders are more prevalent in our species.
Prof. Pierre Vanderhaeghen is looking forward to the future: “This work gives us a clearer picture of the molecular mechanisms that shape the slow development of human synapses. It is amazing to find out that the same genes that are involved in the evolution of the human brain also have the potential to modify the expression of specific brain diseases. This could have important clinical relevance: more research is needed to understand how human-specific mechanisms of brain development affect learning and other behaviors and how their dysregulation can lead to brain disorders. It becomes conceivable that some human-specific gene products could become innovative drug targets.”
Reference: “Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition” by Baptiste Libé-Philippot, Ryohei Iwata, Aleksandra J. Recupero, Keimpe Wierda, Sergio Bernal Garcia, Luke Hammond, Anja van Benthem, Ridha Limame, Martyna Ditkowska, Sofie Beckers, Vaiva Gaspariunaite, Eugénie Peze-Heidsieck, Daan Remans, Cécile Charrier, Tom Theys, Franck Polleux and Pierre Vanderhaeghen, 14 October 2024, Neuron.DOI: 10.1016/j.neuron.2024.08.021
Funding: European Research Council, C1 KU Leuven Internal Funds Programme, EOS Programme, ERA-Net NEURON, Fonds Wetenschappelijk Onderzoek, EU network NSC-Reconstruct, Generet Foundation, NIH/National Institutes of Health, NOMIs Foundation, Belgian Queen Elizabeth Foundation

The Science of Fear in Film

Are you the type of person who enjoys the thrill of a good horror movie? Or perhaps spooky films are more likely to give you nightmares? Love them or loathe them, most people have an opinion about scary movies.
During this Halloween season, many enjoy watching the latest horror flicks or rewatching classics such as Nosferatu, Jaws, and Poltergeist. What are the physiological and psychological reasons behind the desire to be scared?

What is horror?
The word “horror” derives from the Greek word phryke (“shudder”) and describes the spine-tingling physical manifestations of shivering, shuddering, and getting goosebumps (Martin, 2019). Nowadays, horror refers to our emotions, those intense feelings of fear, shock, or disgust. There are two types of horror. A genuine sense of horror is a protective mechanism that is intended to make us feel afraid because it is advantageous to our survival. Then there is “art horror,” the fictional kind, that is created for entertainment purposes. This refers to novels, stories, plays, video games, or movies that explore forbidden, evil, and violent aspects of life (and death). Fictional horror is marked by the presence of the paranormal or the unknown and is often centered around a villain or monster, especially supernatural creatures such as demons, vampires, werewolves, and zombies.

Horror movies impact our minds. They are designed to evoke fear, shock, and disgust, and are intended to disturb, frighten, scare, or even repulse us. They impact our bodies, too. Watching horror can cause unpleasant physical reactions, including anxiety, increased heart rate and blood pressure, insomnia or nightmares, intrusive thoughts, and in some extreme cases, it has been reported to cause a type of trauma known as “cinematic neurosis.” (Ballon et al., 2007)

Then why do so many people love horror movies?
The science of scary movies
Horror has been with us since the earliest recorded culture, notably classical Greek tragedies, which are full of violence, gore, and terror. People enjoyed these dramas for the “catharsis,” the purging of pent-up emotions like fear and pity that led to a sense of renewal. Today, people still enjoy this type of terror, particularly in horror movies, whether it’s a modern sub-genre like a slasher, a haunted house, or found footage film. People enjoy watching scary movies for a variety of reasons. Horror can give rise to negative feelings, such as fear and anxiety, but also positive feelings, including excitement and even euphoria.

Horror movies are stimulating. Watching them can trigger our fight-or-flight response, releasing a rush of adrenaline, endorphins, and dopamine. These feel-good chemicals dull pain, excite mood, and create a natural high, which can become somewhat addictive for sensation seekers. Rather like the idea of “catharsis,” modern studies suggest that part of the attraction of watching horror is the feeling of suspense and tension, and then the resolution of that suspense and tension (Zillman, 1996).

Horror movies are also a way for us to simulate threat and danger and mediate fear. (Clasen et al., 2020) Being frightened in a controlled environment can be fun. It would be terrifying to encounter a true vampire or a werewolf; alternatively, watching Dracula or The Wolfman provides us with a manageable experience that (probably) won’t happen in real life. There is a psychological distance when we watch horror. We know what we’re watching is not real, or at least, some parts of our brain know it isn’t real.

Horror has always been a reflection of our social and cultural fears. It has even been theorized that watching horror may help us to practice coping strategies and prepare us for worst-case scenarios, to navigate that demonic possession, alien invasion, or zombie outbreak. When that threat is real, horror fans may find that they’re better equipped to cope with the stress. One study suggested that participants who enjoyed pandemic-related horror were more psychologically prepared for, and resilient during, the COVID-19 pandemic. (Scrivner, 2021)

THE BASICS

Finally, watching horror is a social experience that helps us to connect with others. Horror movies bring together family and friends to bond over a new film or old favorites such as “The Amityville Horror,” “Night of the Living Dead,” and “The Exorcist.” The shared experience of facing fear together can lead to feelings of safety and also physical and emotional closeness.

With all of this in mind, we can happily continue to enjoy the tradition of watching horror movies during this Halloween season, or at any time of the year.

Junk Science May Seal the Fate of Robert Roberson

This article was originally published by the Texas Observer, a nonprofit investigative news outlet and magazine. Sign up for its weekly newsletter, or follow on Facebook and X.Shortly after this story published on the Texas Observer, the Texas Court of Criminal Appeals dismissed both a habeas corpus application and a motion for stay of execution filed by Robert Roberson’s defense team. This decision means the state’s top criminal court will not intervene to extend Roberson’s life. “Robert’s fate is now at the mercy of [Gov. Greg Abbott]. He and the Texas Board of Pardons and Paroles are the only ones standing in the way of a horrific and irreversible mistake: the execution of an innocent man,” said Roberson’s attorney, Gretchen Sween, in a statement. Roberson is scheduled to die on Oct. 17.The hearing on the innocence claims of a condemned man began on Aug. 14, 2018, with what seemed like a major setback. Defense attorney Gretchen Sween — who represented Robert Roberson III, a father convicted of killing his 27-month-old daughter in 2002 — told Anderson County Judge Deborah Oakes Evans that crucial pieces of evidence were missing. Scans of the young girl’s head, made in the weeks before her death and shortly before she died, were nowhere to be found. Sween believed those lost records could have provided crucial context to Nikki’s death. The day after Nikki was brought to the hospital, a child abuse pediatrician diagnosed “shaken baby syndrome,” and the following day, the pathologist who performed the autopsy declared the death a homicide. If new experts could review those scans, they could help determine whether Nikki truly died of abusive trauma, or whether Roberson’s story that Nikki had fallen out of bed and sustained a head injury was the truth. The jury in Roberson’s original 2003 trial had never seen these scans. Neither had one of the prosecutor’s key witnesses: Jill Urban, a forensic pathologist with the Dallas County Medical Examiner’s Office, who performed Nikki’s autopsy. The scans were referenced in medical records, so attorneys knew they existed — they had been asking for them for years.

The jury in Roberson’s original 2003 trial had never seen these scans.

It seemed as if they would remain forever lost, Sween told the court. Anderson County District Attorney Allyson Mitchell — who took office in 2015, 12 years after Roberson’s initial trial — claimed to have searched their evidence storage areas “from top to bottom” and came up empty, according to a hearing transcript.Roberson, sent to prison 15 years before and now in middle age, watched the hearing over dark-framed glasses. He was clad in a jail-provided black-and-gray striped jumpsuit and sat with his hands on the table, handcuffs around his wrists. He watched Sween question one witness, a nurse who had seen Roberson the morning he took his daughter Nikki into the emergency room, before the court took a brief recess. Then, lawyers from both sides were called into Evans’ chambers to discuss a shocking discovery: The scans had been found. 

Winner of 3M Young Scientist Challenge invents AI pesticide detector for produce

America has a new top young scientist. Fourteen-year-old Sirish Subash — a ninth-grader from Snellville, Ga. — was crowned the winner of the 2024 3M Young Scientist Challenge contest in St. Paul this week. He picked up a cash prize of $25,000 and the lesson that moms are always right. Subash’s invention, Pestiscand, is a handheld device he designed for at-home use to detect pesticide residue on produce without damaging the food. It measures the wavelength of light reflecting off of fruits and vegetables and uses a machine-learning model to analyze the data. Users download a phone app, point Pestiscand at the produce, tap the scan button and voilà, they see if their apple or spinach needs another rinse. “Oftentimes there are these residues from pesticides that are found on produce. If we could detect them, then we could ensure that we weren’t really consuming them,” Subash told MPR News. “That’s the main goal of Pestiscand, to help people ensure that they aren’t consuming pesticides used so they can avoid any associated health risks.” MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. The idea for the invention was sparked from a conversation between Subash and his mom. “My parents always insist that I wash my produce before consuming it. I wondered, how necessary is this really, and how effective is the washing,” he said. “Does it really work to ensure that your produce is clean?”As Subash learned, while intended to kill unwanted pests, the chemicals can also be carcinogenic to humans, cause endocrine or immune system problems, trigger skin reactions and more, according to the Environmental Protection Agency. Some are associated with diseases like Alzheimer’s and Parkinson’s. He didn’t, however, find a device for folks to check if there was pesticide residue on their food, so he decided to fill that gap. Subash said he discovered his interest in science in first grade and wanted to apply for the Challenge but almost missed his shot. Students have to be in fifth through eighth grade at the time of their application. “I had skipped fifth grade, so I couldn’t enter that year. Sixth grade, my family was in India for a good majority of that time, so I wasn’t able to get my project set up that year. Seventh grade, I did enter, but it didn’t work out,” Subash recalled. “So eighth grade, this is, this was my last year to apply. So I wanted to make it worth it, because this has been somewhat of a dream of mine to make it here.” Sirish Subash, a 9th grader from Snellville, Ga., is the winner of the 2024 3M Young Scientist Challenge. He developed an AI handheld pesticide detector called “Pestiscand.” 3M and Discovery Education chose Subash from 10 finalists on Sunday, Oct. 14, 2024.Courtesy of 3MSubash competed against nine other finalists over the last four months with support from a 3M mentor. On Tuesday night he found out his hard work paid off. While Subash, who turned 14 Thursday, isn’t totally certain what his future will look like, he does plan to use some of his prize money for higher education. “One thing I know is that I love physics… And one of the biggest things I want to do is I want to work on devices that will impact everyday people, that will impact everyone’s lives for the better,” Subash said. “That’s one of my that’s one of my goals in life, to [make] a positive mark on the world.” Learn more about Subash and the other Challenge finalists at youngscientistlab.com.

Winner of 3M Young Scientist Challenge invents AI pesticide detector for produce

America has a new top young scientist. Fourteen-year-old Sirish Subash — a ninth-grader from Snellville, Ga. — was crowned the winner of the 2024 3M Young Scientist Challenge contest in St. Paul this week. He picked up a cash prize of $25,000 and the lesson that moms are always right. Subash’s invention, Pestiscand, is a handheld device he designed for at-home use to detect pesticide residue on produce without damaging the food. It measures the wavelength of light reflecting off of fruits and vegetables and uses a machine-learning model to analyze the data. Users download a phone app, point Pestiscand at the produce, tap the scan button and voilà, they see if their apple or spinach needs another rinse. “Oftentimes there are these residues from pesticides that are found on produce. If we could detect them, then we could ensure that we weren’t really consuming them,” Subash told MPR News. “That’s the main goal of Pestiscand, to help people ensure that they aren’t consuming pesticides used so they can avoid any associated health risks.” MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. The idea for the invention was sparked from a conversation between Subash and his mom. “My parents always insist that I wash my produce before consuming it. I wondered, how necessary is this really, and how effective is the washing,” he said. “Does it really work to ensure that your produce is clean?”As Subash learned, while intended to kill unwanted pests, the chemicals can also be carcinogenic to humans, cause endocrine or immune system problems, trigger skin reactions and more, according to the Environmental Protection Agency. Some are associated with diseases like Alzheimer’s and Parkinson’s. He didn’t, however, find a device for folks to check if there was pesticide residue on their food, so he decided to fill that gap. Subash said he discovered his interest in science in first grade and wanted to apply for the Challenge but almost missed his shot. Students have to be in fifth through eighth grade at the time of their application. “I had skipped fifth grade, so I couldn’t enter that year. Sixth grade, my family was in India for a good majority of that time, so I wasn’t able to get my project set up that year. Seventh grade, I did enter, but it didn’t work out,” Subash recalled. “So eighth grade, this is, this was my last year to apply. So I wanted to make it worth it, because this has been somewhat of a dream of mine to make it here.” Sirish Subash, a 9th grader from Snellville, Ga., is the winner of the 2024 3M Young Scientist Challenge. He developed an AI handheld pesticide detector called “Pestiscand.” 3M and Discovery Education chose Subash from 10 finalists on Sunday, Oct. 14, 2024.Courtesy of 3MSubash competed against nine other finalists over the last four months with support from a 3M mentor. On Tuesday night he found out his hard work paid off. While Subash, who turned 14 Thursday, isn’t totally certain what his future will look like, he does plan to use some of his prize money for higher education. “One thing I know is that I love physics… And one of the biggest things I want to do is I want to work on devices that will impact everyday people, that will impact everyone’s lives for the better,” Subash said. “That’s one of my that’s one of my goals in life, to [make] a positive mark on the world.” Learn more about Subash and the other Challenge finalists at youngscientistlab.com.

Pasta Can Be Healthy, Says Nutrition Scientist

At a time when nutrition and wellness influencers are often on low-carbohydrate diets, starchy foods like bread, pasta and fries are rarely the subject of positive health-related attention.But one scientist and doctor, King’s College London professor Tim Spector, co-founder of science and nutrition company Zoe, told Newsweek there’s no need to ditch your pasta to be healthy.”Pasta has historically had a bad reputation due to the recent low-carb trends,” he said. “But there’s certainly no need to avoid pasta—or any carbohydrate.”Many people avoid carbs because of their effect on blood sugar. When we eat starchy foods such as pasta, the body quickly turns these foods into glucose—blood sugar—and then the hormone insulin is released to move the glucose from the bloodstream into cells to be used as energy.Problems can arise if a person is eating too much sugar or carbohydrates, leading to spikes in glucose that require big insulin responses. This can increase the risk of developing insulin resistance, Type 2 diabetes and obesity.”It’s true that white refined pasta is low in fiber and is easy to digest, meaning it can cause more pronounced blood sugar responses if you’re having it on its own. So it’s probably not a good idea to have a big bowl of plain macaroni every day,” Spector said.”But pasta can definitely be part of a healthy diet, and there are lots of ways to add more fiber, healthy fats and proteins from plants into these dishes,” he said.Adding these other nutrients—fiber, fats and proteins—to carbohydrates such as pasta helps slow the release of glucose into the bloodstream, meaning the insulin response will be more gradual, which is better for avoiding diseases such as diabetes.That’s why, Spector said, the pasta itself is not necessarily the problem. More important is the overall meal.”It’s about the quality of the pasta, how much you’re having and what you’re having the pasta with,” he said. “At Zoe, we focus on adding foods to your plate rather than taking them away, so it’s all about having plants in abundance and enjoying delicious meals that will keep you fuller for longer.”So if you’re having a pasta dish full of plants like beans, lentils, extra-virgin olive oil and vegetables, it will pack in a good amount of protein and fiber, creating a balanced meal that’s great for your nutrition and gut health,” he said.

Pictured is pasta penne with roasted tomato, sauce and mozzarella cheese. Eating pasta has been criticized by people who follow low-carbohydrate diets, as it is a starchy carb that can cause blood sugar spikes. But…
Pictured is pasta penne with roasted tomato, sauce and mozzarella cheese. Eating pasta has been criticized by people who follow low-carbohydrate diets, as it is a starchy carb that can cause blood sugar spikes. But one expert says pasta can be part of a healthy diet.
More
AnnaPustynnikova/Getty Images
When pasta cools down, some of it becomes resistant starch, which has a gentler effect on blood sugars, Spector said.So for people who want to eat pasta without experiencing a sharp blood sugar spike, allowing it to cool—and then reheating it if you’d like it hot—could be a good option.Pasta features in the Mediterranean diet, Spector pointed out. This diet is widely considered to be one of the healthiest eating plans in the world, emphasizing vegetables, fruit, whole grains, legumes, fish and olive oil.”In Italy, pasta is eaten regularly but in moderation, often as part of the Mediterranean diet with plenty of vegetables and legumes,” Spector said. “Italy also has one of the lowest rates of obesity in the world.”This contrasts to the U.S. and U.K., where pasta portions tend to be larger. So focusing on portion size can be helpful, as it will leave more room to pack in vegetables.”To boost the nutritional content of a pasta dish, Spector recommends adding a source of fiber and protein—such as cannellini beans—and topping it with extra-virgin olive oil, a healthy fat with antioxidant and anti-inflammatory properties.”Pasta is a fantastic vehicle for flavor, texture and nutrient-dense, fibrous foods,” Spector said. “Most of us aren’t getting enough fiber, and choosing a whole grain pasta rather than white increases the amount of fiber you get.”But if, like me, you don’t enjoy the whole grain version as much, stick with good-quality durum white pasta and simply add more high-fiber vegetables to the sauce instead.”For example, he likes to add kale to tomato-based pasta dishes.Do you have a tip on a food story that Newsweek should be covering? Is there a nutrition concern that’s worrying you? Let us know via [email protected]. We can ask experts for advice, and your story could be featured in Newsweek.

Pasta Can Be Healthy, Says Nutrition Scientist

At a time when nutrition and wellness influencers are often on low-carbohydrate diets, starchy foods like bread, pasta and fries are rarely the subject of positive health-related attention.But one scientist and doctor, King’s College London professor Tim Spector, co-founder of science and nutrition company Zoe, told Newsweek there’s no need to ditch your pasta to be healthy.”Pasta has historically had a bad reputation due to the recent low-carb trends,” he said. “But there’s certainly no need to avoid pasta—or any carbohydrate.”Many people avoid carbs because of their effect on blood sugar. When we eat starchy foods such as pasta, the body quickly turns these foods into glucose—blood sugar—and then the hormone insulin is released to move the glucose from the bloodstream into cells to be used as energy.Problems can arise if a person is eating too much sugar or carbohydrates, leading to spikes in glucose that require big insulin responses. This can increase the risk of developing insulin resistance, Type 2 diabetes and obesity.”It’s true that white refined pasta is low in fiber and is easy to digest, meaning it can cause more pronounced blood sugar responses if you’re having it on its own. So it’s probably not a good idea to have a big bowl of plain macaroni every day,” Spector said.”But pasta can definitely be part of a healthy diet, and there are lots of ways to add more fiber, healthy fats and proteins from plants into these dishes,” he said.Adding these other nutrients—fiber, fats and proteins—to carbohydrates such as pasta helps slow the release of glucose into the bloodstream, meaning the insulin response will be more gradual, which is better for avoiding diseases such as diabetes.That’s why, Spector said, the pasta itself is not necessarily the problem. More important is the overall meal.”It’s about the quality of the pasta, how much you’re having and what you’re having the pasta with,” he said. “At Zoe, we focus on adding foods to your plate rather than taking them away, so it’s all about having plants in abundance and enjoying delicious meals that will keep you fuller for longer.”So if you’re having a pasta dish full of plants like beans, lentils, extra-virgin olive oil and vegetables, it will pack in a good amount of protein and fiber, creating a balanced meal that’s great for your nutrition and gut health,” he said.

Pictured is pasta penne with roasted tomato, sauce and mozzarella cheese. Eating pasta has been criticized by people who follow low-carbohydrate diets, as it is a starchy carb that can cause blood sugar spikes. But…
Pictured is pasta penne with roasted tomato, sauce and mozzarella cheese. Eating pasta has been criticized by people who follow low-carbohydrate diets, as it is a starchy carb that can cause blood sugar spikes. But one expert says pasta can be part of a healthy diet.
More
AnnaPustynnikova/Getty Images
When pasta cools down, some of it becomes resistant starch, which has a gentler effect on blood sugars, Spector said.So for people who want to eat pasta without experiencing a sharp blood sugar spike, allowing it to cool—and then reheating it if you’d like it hot—could be a good option.Pasta features in the Mediterranean diet, Spector pointed out. This diet is widely considered to be one of the healthiest eating plans in the world, emphasizing vegetables, fruit, whole grains, legumes, fish and olive oil.”In Italy, pasta is eaten regularly but in moderation, often as part of the Mediterranean diet with plenty of vegetables and legumes,” Spector said. “Italy also has one of the lowest rates of obesity in the world.”This contrasts to the U.S. and U.K., where pasta portions tend to be larger. So focusing on portion size can be helpful, as it will leave more room to pack in vegetables.”To boost the nutritional content of a pasta dish, Spector recommends adding a source of fiber and protein—such as cannellini beans—and topping it with extra-virgin olive oil, a healthy fat with antioxidant and anti-inflammatory properties.”Pasta is a fantastic vehicle for flavor, texture and nutrient-dense, fibrous foods,” Spector said. “Most of us aren’t getting enough fiber, and choosing a whole grain pasta rather than white increases the amount of fiber you get.”But if, like me, you don’t enjoy the whole grain version as much, stick with good-quality durum white pasta and simply add more high-fiber vegetables to the sauce instead.”For example, he likes to add kale to tomato-based pasta dishes.Do you have a tip on a food story that Newsweek should be covering? Is there a nutrition concern that’s worrying you? Let us know via [email protected]. We can ask experts for advice, and your story could be featured in Newsweek.